{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:56:56Z","timestamp":1792299416326,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00277-022-04966-w","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:02:16Z","timestamp":1661558536000},"page":"2413-2419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin\u2013based IST in Chinese patients with severe aplastic anemia"],"prefix":"10.1007","volume":"101","author":[{"given":"Yuanyuan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-5897","authenticated-orcid":false,"given":"Guangsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"issue":"3","key":"4966_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/cei.12605","volume":"180","author":"Y Zeng","year":"2015","unstructured":"Zeng Y, Katsanis E (2015) The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol 180(3):361\u2013370","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"4966_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.hoc.2018.03.001","volume":"32","author":"ML Schoettler","year":"2018","unstructured":"Schoettler ML, Nathan DG (2018) The pathophysiology of acquired aplastic anemia: current concepts revisited. Hematol Oncol Clin North Am 32(4):581\u2013594","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9471","key":"4966_CR3","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(05)66515-4","volume":"365","author":"RA Brodsky","year":"2005","unstructured":"Brodsky RA, Jones RJ (2005) Aplastic anaemia. Lancet 365(9471):1647\u20131656","journal-title":"Lancet"},{"issue":"4","key":"4966_CR4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1182\/blood-2002-04-1134","volume":"101","author":"N Frickhofen","year":"2003","unstructured":"Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H, German Aplastic Anemia Study G (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 101(4):1236\u201342","journal-title":"Blood"},{"issue":"5","key":"4966_CR5","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1182\/blood.V85.5.1348.bloodjournal8551348","volume":"85","author":"A Bacigalupo","year":"1995","unstructured":"Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G et al (1995) Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85(5):1348\u20131353","journal-title":"Blood"},{"issue":"1","key":"4966_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1200931","volume":"367","author":"MJ Olnes","year":"2012","unstructured":"Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE (2012) Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med 367(1):11\u201319","journal-title":"N Engl J Med"},{"issue":"12","key":"4966_CR7","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","volume":"123","author":"R Desmond","year":"2014","unstructured":"Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE (2014) Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood 123(12):1818\u20131825","journal-title":"Blood"},{"issue":"16","key":"4966_CR8","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS (2017) Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med 376(16):1540\u20131550","journal-title":"N Engl J Med"},{"issue":"1","key":"4966_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","volume":"386","author":"R de PeffaultLatour","year":"2022","unstructured":"de Peffault Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, Sanchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, de SicreFontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Socie G, Mufti GJ, Dufour C, Risitano AM, Severe Aplastic Anemia Working Party of the European Society for B, Marrow T (2022) Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med 386(1):11\u201323","journal-title":"N Engl J Med"},{"issue":"5","key":"4966_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/2040620717693573","volume":"8","author":"H Gill","year":"2017","unstructured":"Gill H, Wong RSM, Kwong YL (2017) From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag. Ther Adv Hematol 8(5):159\u2013174","journal-title":"Ther Adv Hematol"},{"issue":"23","key":"4966_CR11","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1182\/blood-2012-02-407684","volume":"119","author":"JC Marsh","year":"2012","unstructured":"Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR, Killick SB, Warren AJ, Foukaneli T, Aljurf M, Al-Zahrani HA, Hochsmann B, Schafhausen P, Roth A, Franzke A, Brummendorf TH, Dufour C, Oneto R, Sedgwick P, Barrois A, Kordasti S, Elebute MO, Mufti GJ, Socie G, European B, Marrow Transplant Group Severe Aplastic Anaemia Working P (2012) Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood 119(23):5391\u20136","journal-title":"Blood"},{"issue":"22","key":"4966_CR12","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1182\/blood-2010-04-281717","volume":"116","author":"W Bao","year":"2010","unstructured":"Bao W, Bussel JB, Heck S, He W, Karpoff M, Boulad N, Yazdanbakhsh K (2010) Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood 116(22):4639\u20134645","journal-title":"Blood"},{"issue":"Suppl 1","key":"4966_CR13","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1053\/j.seminhematol.2016.04.010","volume":"53","author":"A Schifferli","year":"2016","unstructured":"Schifferli A, Kuhne T (2016) Thrombopoietin receptor agonists: a new immune modulatory strategy in immune thrombocytopenia? Semin Hematol 53(Suppl 1):S31\u2013S34","journal-title":"Semin Hematol"},{"issue":"19","key":"4966_CR14","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2018-11-884486","volume":"133","author":"LJ Alvarado","year":"2019","unstructured":"Alvarado LJ, Huntsman HD, Cheng H, Townsley DM, Winkler T, Feng X, Dunbar CE, Young NS, Larochelle A (2019) Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-gamma. Blood 133(19):2043\u20132055","journal-title":"Blood"},{"issue":"4","key":"4966_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s12185-016-2053-8","volume":"104","author":"S Chuncharunee","year":"2016","unstructured":"Chuncharunee S, Wong R, Rojnuckarin P, Chang CS, Chang KM, Lu MY, Hwang WL, Koh LP, Chen TY, Leung AY, Norasetthada L, Wang SC, Chang MC, Wu KH, Issaragrisil S (2016) Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study. Int J Hematol 104(4):454\u2013461","journal-title":"Int J Hematol"},{"issue":"6","key":"4966_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00277-013-1674-8","volume":"92","author":"SH Shin","year":"2013","unstructured":"Shin SH, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Kim DW, Min WS, Park CW, Lee JW (2013) The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol 92(6):817\u2013824","journal-title":"Ann Hematol"},{"issue":"21","key":"4966_CR17","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1002\/cncr.31658","volume":"124","author":"R Assi","year":"2018","unstructured":"Assi R, Garcia-Manero G, Ravandi F, Borthakur G, Daver NG, Jabbour E, Burger J, Estrov Z, Dinardo CD, Alvarado Y, Hendrickson S, Ferrajoli A, Wierda W, Cortes J, Kantarjian H, Kadia TM (2018) Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia. Cancer 124(21):4192\u20134201","journal-title":"Cancer"},{"issue":"5","key":"4966_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJMoa1103975","volume":"365","author":"P Scheinberg","year":"2011","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, Young NS (2011) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 365(5):430\u2013438","journal-title":"N Engl J Med"},{"issue":"6","key":"4966_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00277-015-2305-3","volume":"94","author":"C Vallejo","year":"2015","unstructured":"Vallejo C, Montesinos P, Polo M, Cuevas B, Morado M, Rosell A, Xicoy B, Diez JL, Salamero O, Cedillo A, Martinez P, Rayon C, Bone Marrow Failure Spanish Study G (2015) Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis. Ann Hematol 94(6):947\u201354","journal-title":"Ann Hematol"},{"issue":"4","key":"4966_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12185-016-2046-7","volume":"104","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Kobayashi H, Kawasaki Y, Okazuka K, Hatano K, Fujiwara S, Oh I, Ohmine K, Kanda Y (2016) Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations. Int J Hematol 104(4):446\u2013453","journal-title":"Int J Hematol"},{"issue":"1","key":"4966_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood.2021012130","volume":"139","author":"BA Patel","year":"2022","unstructured":"Patel BA, Groarke EM, Lotter J, Shalhoub R, Gutierrez-Rodrigues F, Rios O, Quinones Raffo D, Wu CO, Young NS (2022) Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study. Blood 139(1):34\u201343","journal-title":"Blood"},{"issue":"7","key":"4966_CR22","first-page":"585","volume":"52","author":"YX Sun","year":"2013","unstructured":"Sun YX, Zhu MQ, He GS, Wang XL, Fang BZ, Lu C, Liu ZZ, Wu Q, Yang Y, Wu DP, Sun AN (2013) The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy. Zhonghua Nei Ke Za Zhi 52(7):585\u2013589","journal-title":"Zhonghua Nei Ke Za Zhi"}],"updated-by":[{"DOI":"10.1007\/s00277-023-05107-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000}}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04966-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04966-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04966-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T04:41:46Z","timestamp":1674708106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04966-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4966"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04966-w","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00277-023-05107-7","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]},"assertion":[{"value":"26 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00277-023-05107-7","URL":"https:\/\/doi.org\/10.1007\/s00277-023-05107-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}